nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazepam—PTGS1—esophageal cancer	0.413	0.673	CbGaD
Diazepam—ABCB1—esophageal cancer	0.201	0.327	CbGaD
Diazepam—CYP2C9—Capecitabine—esophageal cancer	0.0186	0.258	CbGbCtD
Diazepam—CYP2B6—Cisplatin—esophageal cancer	0.0177	0.246	CbGbCtD
Diazepam—ALB—Methotrexate—esophageal cancer	0.0113	0.157	CbGbCtD
Diazepam—CYP2C9—Cisplatin—esophageal cancer	0.00936	0.13	CbGbCtD
Diazepam—ABCB1—Cisplatin—esophageal cancer	0.00909	0.126	CbGbCtD
Diazepam—ABCB1—Methotrexate—esophageal cancer	0.0059	0.082	CbGbCtD
Diazepam—TSPO—exocrine gland—esophageal cancer	0.00145	0.068	CbGeAlD
Diazepam—GABRA3—neck—esophageal cancer	0.00134	0.063	CbGeAlD
Diazepam—CYP2C18—bronchus—esophageal cancer	0.00115	0.0539	CbGeAlD
Diazepam—Otitis media—Capecitabine—esophageal cancer	0.000935	0.00758	CcSEcCtD
Diazepam—Fracture—Methotrexate—esophageal cancer	0.000933	0.00756	CcSEcCtD
Diazepam—Multiple fractures—Methotrexate—esophageal cancer	0.000933	0.00756	CcSEcCtD
Diazepam—Memory impairment—Capecitabine—esophageal cancer	0.000928	0.00752	CcSEcCtD
Diazepam—TSPO—neck—esophageal cancer	0.000926	0.0435	CbGeAlD
Diazepam—CYP2C18—digestive system—esophageal cancer	0.000887	0.0416	CbGeAlD
Diazepam—GABRP—bronchus—esophageal cancer	0.000871	0.0409	CbGeAlD
Diazepam—Hypoxia—Methotrexate—esophageal cancer	0.000853	0.00692	CcSEcCtD
Diazepam—Phlebitis—Cisplatin—esophageal cancer	0.000832	0.00675	CcSEcCtD
Diazepam—Skin discolouration—Capecitabine—esophageal cancer	0.000806	0.00654	CcSEcCtD
Diazepam—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000806	0.00654	CcSEcCtD
Diazepam—GABRP—trachea—esophageal cancer	0.000782	0.0367	CbGeAlD
Diazepam—Dysarthria—Capecitabine—esophageal cancer	0.00077	0.00624	CcSEcCtD
Diazepam—Cyanosis—Methotrexate—esophageal cancer	0.000766	0.00621	CcSEcCtD
Diazepam—Amnesia—Cisplatin—esophageal cancer	0.000763	0.00619	CcSEcCtD
Diazepam—Coordination abnormal—Capecitabine—esophageal cancer	0.000742	0.00601	CcSEcCtD
Diazepam—Hiccups—Capecitabine—esophageal cancer	0.000728	0.0059	CcSEcCtD
Diazepam—Stupor—Methotrexate—esophageal cancer	0.000726	0.00589	CcSEcCtD
Diazepam—Injection site reaction—Capecitabine—esophageal cancer	0.000724	0.00587	CcSEcCtD
Diazepam—Urinary incontinence—Capecitabine—esophageal cancer	0.000703	0.0057	CcSEcCtD
Diazepam—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000703	0.0057	CcSEcCtD
Diazepam—Dehydration—Cisplatin—esophageal cancer	0.000667	0.00541	CcSEcCtD
Diazepam—GABRE—bronchus—esophageal cancer	0.000665	0.0312	CbGeAlD
Diazepam—Ecchymosis—Capecitabine—esophageal cancer	0.000658	0.00534	CcSEcCtD
Diazepam—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000655	0.00531	CcSEcCtD
Diazepam—Cramp muscle—Cisplatin—esophageal cancer	0.000646	0.00524	CcSEcCtD
Diazepam—Abnormal vision—Capecitabine—esophageal cancer	0.000635	0.00515	CcSEcCtD
Diazepam—Mental disability—Capecitabine—esophageal cancer	0.000632	0.00512	CcSEcCtD
Diazepam—Speech disorder—Methotrexate—esophageal cancer	0.00063	0.00511	CcSEcCtD
Diazepam—TSPO—epithelium—esophageal cancer	0.00063	0.0296	CbGeAlD
Diazepam—TSPO—bronchus—esophageal cancer	0.000621	0.0291	CbGeAlD
Diazepam—Phlebitis—Capecitabine—esophageal cancer	0.000614	0.00497	CcSEcCtD
Diazepam—Sleep disorder—Capecitabine—esophageal cancer	0.000611	0.00495	CcSEcCtD
Diazepam—TSPO—smooth muscle tissue—esophageal cancer	0.000607	0.0285	CbGeAlD
Diazepam—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000605	0.0049	CcSEcCtD
Diazepam—Photosensitivity—Capecitabine—esophageal cancer	0.000602	0.00488	CcSEcCtD
Diazepam—Skin discolouration—Methotrexate—esophageal cancer	0.0006	0.00487	CcSEcCtD
Diazepam—Swelling—Capecitabine—esophageal cancer	0.000599	0.00486	CcSEcCtD
Diazepam—GABRE—trachea—esophageal cancer	0.000597	0.028	CbGeAlD
Diazepam—Dysarthria—Methotrexate—esophageal cancer	0.000573	0.00465	CcSEcCtD
Diazepam—Increased appetite—Capecitabine—esophageal cancer	0.000563	0.00456	CcSEcCtD
Diazepam—Amnesia—Capecitabine—esophageal cancer	0.000563	0.00456	CcSEcCtD
Diazepam—GABRP—lung—esophageal cancer	0.000562	0.0264	CbGeAlD
Diazepam—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00056	0.00454	CcSEcCtD
Diazepam—TSPO—trachea—esophageal cancer	0.000557	0.0261	CbGeAlD
Diazepam—Thirst—Capecitabine—esophageal cancer	0.000555	0.0045	CcSEcCtD
Diazepam—Respiratory failure—Methotrexate—esophageal cancer	0.000552	0.00448	CcSEcCtD
Diazepam—GABRR2—lymph node—esophageal cancer	0.000549	0.0258	CbGeAlD
Diazepam—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000545	0.00442	CcSEcCtD
Diazepam—Renal failure—Cisplatin—esophageal cancer	0.000543	0.0044	CcSEcCtD
Diazepam—Myocardial infarction—Cisplatin—esophageal cancer	0.000542	0.00439	CcSEcCtD
Diazepam—Cardiac failure—Capecitabine—esophageal cancer	0.000542	0.00439	CcSEcCtD
Diazepam—Lethargy—Capecitabine—esophageal cancer	0.000539	0.00437	CcSEcCtD
Diazepam—Conjunctivitis—Cisplatin—esophageal cancer	0.000537	0.00436	CcSEcCtD
Diazepam—Diplopia—Capecitabine—esophageal cancer	0.000529	0.00429	CcSEcCtD
Diazepam—Osteoarthritis—Capecitabine—esophageal cancer	0.000529	0.00429	CcSEcCtD
Diazepam—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000524	0.00425	CcSEcCtD
Diazepam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000523	0.00424	CcSEcCtD
Diazepam—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000523	0.00424	CcSEcCtD
Diazepam—Bradycardia—Cisplatin—esophageal cancer	0.000505	0.00409	CcSEcCtD
Diazepam—Urinary retention—Capecitabine—esophageal cancer	0.000503	0.00408	CcSEcCtD
Diazepam—Cardiac arrest—Capecitabine—esophageal cancer	0.000503	0.00408	CcSEcCtD
Diazepam—Mood swings—Capecitabine—esophageal cancer	0.000501	0.00406	CcSEcCtD
Diazepam—Ataxia—Capecitabine—esophageal cancer	0.000497	0.00403	CcSEcCtD
Diazepam—Dehydration—Capecitabine—esophageal cancer	0.000492	0.00399	CcSEcCtD
Diazepam—Ecchymosis—Methotrexate—esophageal cancer	0.00049	0.00397	CcSEcCtD
Diazepam—Urinary tract disorder—Cisplatin—esophageal cancer	0.00049	0.00397	CcSEcCtD
Diazepam—Urethral disorder—Cisplatin—esophageal cancer	0.000486	0.00394	CcSEcCtD
Diazepam—Gynaecomastia—Methotrexate—esophageal cancer	0.000485	0.00393	CcSEcCtD
Diazepam—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000483	0.00391	CcSEcCtD
Diazepam—TSPO—digestive system—esophageal cancer	0.00048	0.0225	CbGeAlD
Diazepam—Visual impairment—Cisplatin—esophageal cancer	0.000478	0.00388	CcSEcCtD
Diazepam—GABRB2—lung—esophageal cancer	0.000473	0.0222	CbGeAlD
Diazepam—Muscular weakness—Capecitabine—esophageal cancer	0.000466	0.00378	CcSEcCtD
Diazepam—Eye disorder—Cisplatin—esophageal cancer	0.000464	0.00376	CcSEcCtD
Diazepam—Lymphadenopathy—Methotrexate—esophageal cancer	0.000461	0.00374	CcSEcCtD
Diazepam—Cardiac disorder—Cisplatin—esophageal cancer	0.00046	0.00373	CcSEcCtD
Diazepam—Asthma—Capecitabine—esophageal cancer	0.000457	0.0037	CcSEcCtD
Diazepam—Dysphagia—Capecitabine—esophageal cancer	0.000457	0.0037	CcSEcCtD
Diazepam—Photosensitivity—Methotrexate—esophageal cancer	0.000448	0.00363	CcSEcCtD
Diazepam—Arrhythmia—Cisplatin—esophageal cancer	0.000443	0.00359	CcSEcCtD
Diazepam—Erythema—Cisplatin—esophageal cancer	0.000432	0.0035	CcSEcCtD
Diazepam—Malnutrition—Cisplatin—esophageal cancer	0.000432	0.0035	CcSEcCtD
Diazepam—GABRE—lung—esophageal cancer	0.000429	0.0201	CbGeAlD
Diazepam—Neutropenia—Capecitabine—esophageal cancer	0.000427	0.00346	CcSEcCtD
Diazepam—Dysuria—Capecitabine—esophageal cancer	0.000427	0.00346	CcSEcCtD
Diazepam—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000417	0.00338	CcSEcCtD
Diazepam—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000417	0.00338	CcSEcCtD
Diazepam—Visual disturbance—Methotrexate—esophageal cancer	0.000415	0.00337	CcSEcCtD
Diazepam—Muscle spasms—Cisplatin—esophageal cancer	0.000415	0.00337	CcSEcCtD
Diazepam—Pneumonia—Capecitabine—esophageal cancer	0.00041	0.00332	CcSEcCtD
Diazepam—Vision blurred—Cisplatin—esophageal cancer	0.000407	0.0033	CcSEcCtD
Diazepam—Depression—Capecitabine—esophageal cancer	0.000406	0.00329	CcSEcCtD
Diazepam—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000402	0.00326	CcSEcCtD
Diazepam—Lethargy—Methotrexate—esophageal cancer	0.000402	0.00326	CcSEcCtD
Diazepam—TSPO—lung—esophageal cancer	0.0004	0.0188	CbGeAlD
Diazepam—Renal failure—Capecitabine—esophageal cancer	0.0004	0.00325	CcSEcCtD
Diazepam—Myocardial infarction—Capecitabine—esophageal cancer	0.000399	0.00324	CcSEcCtD
Diazepam—Anaemia—Cisplatin—esophageal cancer	0.000399	0.00324	CcSEcCtD
Diazepam—Jaundice—Capecitabine—esophageal cancer	0.000397	0.00322	CcSEcCtD
Diazepam—Conjunctivitis—Capecitabine—esophageal cancer	0.000396	0.00321	CcSEcCtD
Diazepam—Urinary tract infection—Capecitabine—esophageal cancer	0.000396	0.00321	CcSEcCtD
Diazepam—Osteoarthritis—Methotrexate—esophageal cancer	0.000394	0.00319	CcSEcCtD
Diazepam—Leukopenia—Cisplatin—esophageal cancer	0.000387	0.00313	CcSEcCtD
Diazepam—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000385	0.00312	CcSEcCtD
Diazepam—CYP2B6—bronchus—esophageal cancer	0.000382	0.0179	CbGeAlD
Diazepam—Agranulocytosis—Capecitabine—esophageal cancer	0.00038	0.00308	CcSEcCtD
Diazepam—CYP2C19—digestive system—esophageal cancer	0.000377	0.0177	CbGeAlD
Diazepam—Mood swings—Methotrexate—esophageal cancer	0.000373	0.00302	CcSEcCtD
Diazepam—Bradycardia—Capecitabine—esophageal cancer	0.000372	0.00302	CcSEcCtD
Diazepam—Ataxia—Methotrexate—esophageal cancer	0.00037	0.003	CcSEcCtD
Diazepam—Flunitrazepam—CYP2A6—esophageal cancer	0.000368	0.135	CrCbGaD
Diazepam—Myalgia—Cisplatin—esophageal cancer	0.000368	0.00298	CcSEcCtD
Diazepam—Rhinitis—Capecitabine—esophageal cancer	0.000367	0.00297	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000365	0.00296	CcSEcCtD
Diazepam—Hypoaesthesia—Capecitabine—esophageal cancer	0.000364	0.00295	CcSEcCtD
Diazepam—GABRB3—lung—esophageal cancer	0.000364	0.0171	CbGeAlD
Diazepam—Discomfort—Cisplatin—esophageal cancer	0.000363	0.00295	CcSEcCtD
Diazepam—Urinary tract disorder—Capecitabine—esophageal cancer	0.000361	0.00293	CcSEcCtD
Diazepam—Oedema peripheral—Capecitabine—esophageal cancer	0.00036	0.00292	CcSEcCtD
Diazepam—Urethral disorder—Capecitabine—esophageal cancer	0.000358	0.00291	CcSEcCtD
Diazepam—Anaphylactic shock—Cisplatin—esophageal cancer	0.000352	0.00286	CcSEcCtD
Diazepam—Visual impairment—Capecitabine—esophageal cancer	0.000352	0.00286	CcSEcCtD
Diazepam—PTGS1—epithelium—esophageal cancer	0.000351	0.0165	CbGeAlD
Diazepam—Infection—Cisplatin—esophageal cancer	0.00035	0.00284	CcSEcCtD
Diazepam—Nervous system disorder—Cisplatin—esophageal cancer	0.000346	0.0028	CcSEcCtD
Diazepam—Thrombocytopenia—Cisplatin—esophageal cancer	0.000345	0.0028	CcSEcCtD
Diazepam—Tachycardia—Cisplatin—esophageal cancer	0.000344	0.00279	CcSEcCtD
Diazepam—Skin disorder—Cisplatin—esophageal cancer	0.000342	0.00278	CcSEcCtD
Diazepam—Eye disorder—Capecitabine—esophageal cancer	0.000342	0.00277	CcSEcCtD
Diazepam—Hyperhidrosis—Cisplatin—esophageal cancer	0.000341	0.00276	CcSEcCtD
Diazepam—Asthma—Methotrexate—esophageal cancer	0.00034	0.00276	CcSEcCtD
Diazepam—Cardiac disorder—Capecitabine—esophageal cancer	0.000339	0.00275	CcSEcCtD
Diazepam—PTGS1—smooth muscle tissue—esophageal cancer	0.000338	0.0159	CbGeAlD
Diazepam—Anorexia—Cisplatin—esophageal cancer	0.000336	0.00272	CcSEcCtD
Diazepam—Angiopathy—Capecitabine—esophageal cancer	0.000332	0.00269	CcSEcCtD
Diazepam—Flurbiprofen—PTGS1—esophageal cancer	0.00033	0.121	CrCbGaD
Diazepam—Hypotension—Cisplatin—esophageal cancer	0.000329	0.00267	CcSEcCtD
Diazepam—Chills—Capecitabine—esophageal cancer	0.000328	0.00266	CcSEcCtD
Diazepam—Arrhythmia—Capecitabine—esophageal cancer	0.000327	0.00265	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000321	0.0026	CcSEcCtD
Diazepam—Mental disorder—Capecitabine—esophageal cancer	0.00032	0.0026	CcSEcCtD
Diazepam—Malnutrition—Capecitabine—esophageal cancer	0.000318	0.00258	CcSEcCtD
Diazepam—Erythema—Capecitabine—esophageal cancer	0.000318	0.00258	CcSEcCtD
Diazepam—Neutropenia—Methotrexate—esophageal cancer	0.000318	0.00258	CcSEcCtD
Diazepam—Dysuria—Methotrexate—esophageal cancer	0.000318	0.00258	CcSEcCtD
Diazepam—Paraesthesia—Cisplatin—esophageal cancer	0.000317	0.00257	CcSEcCtD
Diazepam—Dyspnoea—Cisplatin—esophageal cancer	0.000314	0.00255	CcSEcCtD
Diazepam—Erectile dysfunction—Methotrexate—esophageal cancer	0.000313	0.00254	CcSEcCtD
Diazepam—Dysgeusia—Capecitabine—esophageal cancer	0.000312	0.00253	CcSEcCtD
Diazepam—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00031	0.00252	CcSEcCtD
Diazepam—PTGS1—trachea—esophageal cancer	0.00031	0.0145	CbGeAlD
Diazepam—Back pain—Capecitabine—esophageal cancer	0.000308	0.0025	CcSEcCtD
Diazepam—CYP1A2—digestive system—esophageal cancer	0.000308	0.0144	CbGeAlD
Diazepam—Decreased appetite—Cisplatin—esophageal cancer	0.000306	0.00248	CcSEcCtD
Diazepam—Muscle spasms—Capecitabine—esophageal cancer	0.000306	0.00248	CcSEcCtD
Diazepam—Pneumonia—Methotrexate—esophageal cancer	0.000305	0.00247	CcSEcCtD
Diazepam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000304	0.00247	CcSEcCtD
Diazepam—Drowsiness—Methotrexate—esophageal cancer	0.000303	0.00246	CcSEcCtD
Diazepam—Depression—Methotrexate—esophageal cancer	0.000302	0.00245	CcSEcCtD
Diazepam—Pain—Cisplatin—esophageal cancer	0.000301	0.00244	CcSEcCtD
Diazepam—Clozapine—CYP1B1—esophageal cancer	0.000301	0.11	CrCbGaD
Diazepam—Vision blurred—Capecitabine—esophageal cancer	0.0003	0.00243	CcSEcCtD
Diazepam—Renal failure—Methotrexate—esophageal cancer	0.000298	0.00242	CcSEcCtD
Diazepam—CYP3A5—digestive system—esophageal cancer	0.000297	0.0139	CbGeAlD
Diazepam—GABRA2—lymph node—esophageal cancer	0.000296	0.0139	CbGeAlD
Diazepam—Flurazepam—CYP2A6—esophageal cancer	0.000295	0.108	CrCbGaD
Diazepam—CYP2B6—digestive system—esophageal cancer	0.000295	0.0138	CbGeAlD
Diazepam—Conjunctivitis—Methotrexate—esophageal cancer	0.000295	0.00239	CcSEcCtD
Diazepam—Anaemia—Capecitabine—esophageal cancer	0.000294	0.00239	CcSEcCtD
Diazepam—GABRE—lymph node—esophageal cancer	0.000293	0.0138	CbGeAlD
Diazepam—CYP2C9—digestive system—esophageal cancer	0.000292	0.0137	CbGeAlD
Diazepam—Sweating—Methotrexate—esophageal cancer	0.000291	0.00236	CcSEcCtD
Diazepam—Feeling abnormal—Cisplatin—esophageal cancer	0.00029	0.00235	CcSEcCtD
Diazepam—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000287	0.00233	CcSEcCtD
Diazepam—Vertigo—Capecitabine—esophageal cancer	0.000286	0.00232	CcSEcCtD
Diazepam—Syncope—Capecitabine—esophageal cancer	0.000285	0.00231	CcSEcCtD
Diazepam—Leukopenia—Capecitabine—esophageal cancer	0.000285	0.00231	CcSEcCtD
Diazepam—Agranulocytosis—Methotrexate—esophageal cancer	0.000283	0.00229	CcSEcCtD
Diazepam—Palpitations—Capecitabine—esophageal cancer	0.000281	0.00228	CcSEcCtD
Diazepam—Loss of consciousness—Capecitabine—esophageal cancer	0.00028	0.00227	CcSEcCtD
Diazepam—Cough—Capecitabine—esophageal cancer	0.000278	0.00225	CcSEcCtD
Diazepam—CYP2E1—digestive system—esophageal cancer	0.000277	0.013	CbGeAlD
Diazepam—TSPO—lymph node—esophageal cancer	0.000274	0.0128	CbGeAlD
Diazepam—Arthralgia—Capecitabine—esophageal cancer	0.000271	0.0022	CcSEcCtD
Diazepam—Myalgia—Capecitabine—esophageal cancer	0.000271	0.0022	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000269	0.00218	CcSEcCtD
Diazepam—Urinary tract disorder—Methotrexate—esophageal cancer	0.000269	0.00218	CcSEcCtD
Diazepam—Discomfort—Capecitabine—esophageal cancer	0.000268	0.00217	CcSEcCtD
Diazepam—ALB—lymph node—esophageal cancer	0.000267	0.0125	CbGeAlD
Diazepam—Urethral disorder—Methotrexate—esophageal cancer	0.000267	0.00216	CcSEcCtD
Diazepam—PTGS1—digestive system—esophageal cancer	0.000267	0.0125	CbGeAlD
Diazepam—Dry mouth—Capecitabine—esophageal cancer	0.000265	0.00215	CcSEcCtD
Diazepam—Visual impairment—Methotrexate—esophageal cancer	0.000262	0.00213	CcSEcCtD
Diazepam—Confusional state—Capecitabine—esophageal cancer	0.000262	0.00212	CcSEcCtD
Diazepam—Hypersensitivity—Cisplatin—esophageal cancer	0.00026	0.00211	CcSEcCtD
Diazepam—Infection—Capecitabine—esophageal cancer	0.000258	0.00209	CcSEcCtD
Diazepam—CYP1A2—lung—esophageal cancer	0.000257	0.0121	CbGeAlD
Diazepam—Shock—Capecitabine—esophageal cancer	0.000256	0.00207	CcSEcCtD
Diazepam—Nervous system disorder—Capecitabine—esophageal cancer	0.000255	0.00207	CcSEcCtD
Diazepam—Eye disorder—Methotrexate—esophageal cancer	0.000254	0.00206	CcSEcCtD
Diazepam—Thrombocytopenia—Capecitabine—esophageal cancer	0.000254	0.00206	CcSEcCtD
Diazepam—Tachycardia—Capecitabine—esophageal cancer	0.000254	0.00206	CcSEcCtD
Diazepam—Asthenia—Cisplatin—esophageal cancer	0.000253	0.00205	CcSEcCtD
Diazepam—Cardiac disorder—Methotrexate—esophageal cancer	0.000253	0.00205	CcSEcCtD
Diazepam—Skin disorder—Capecitabine—esophageal cancer	0.000252	0.00205	CcSEcCtD
Diazepam—Hyperhidrosis—Capecitabine—esophageal cancer	0.000251	0.00204	CcSEcCtD
Diazepam—CYP3A5—lung—esophageal cancer	0.000248	0.0116	CbGeAlD
Diazepam—Anorexia—Capecitabine—esophageal cancer	0.000248	0.00201	CcSEcCtD
Diazepam—Angiopathy—Methotrexate—esophageal cancer	0.000247	0.002	CcSEcCtD
Diazepam—CYP2B6—lung—esophageal cancer	0.000247	0.0116	CbGeAlD
Diazepam—Chills—Methotrexate—esophageal cancer	0.000244	0.00198	CcSEcCtD
Diazepam—Hypotension—Capecitabine—esophageal cancer	0.000243	0.00197	CcSEcCtD
Diazepam—Diarrhoea—Cisplatin—esophageal cancer	0.000241	0.00196	CcSEcCtD
Diazepam—Mental disorder—Methotrexate—esophageal cancer	0.000239	0.00193	CcSEcCtD
Diazepam—Erythema—Methotrexate—esophageal cancer	0.000237	0.00192	CcSEcCtD
Diazepam—Malnutrition—Methotrexate—esophageal cancer	0.000237	0.00192	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000237	0.00192	CcSEcCtD
Diazepam—Insomnia—Capecitabine—esophageal cancer	0.000235	0.00191	CcSEcCtD
Diazepam—Paraesthesia—Capecitabine—esophageal cancer	0.000233	0.00189	CcSEcCtD
Diazepam—Dysgeusia—Methotrexate—esophageal cancer	0.000232	0.00188	CcSEcCtD
Diazepam—Clozapine—CYP2A6—esophageal cancer	0.000232	0.0848	CrCbGaD
Diazepam—Dyspnoea—Capecitabine—esophageal cancer	0.000232	0.00188	CcSEcCtD
Diazepam—CYP2E1—lung—esophageal cancer	0.000231	0.0109	CbGeAlD
Diazepam—Back pain—Methotrexate—esophageal cancer	0.000229	0.00186	CcSEcCtD
Diazepam—Dyspepsia—Capecitabine—esophageal cancer	0.000229	0.00185	CcSEcCtD
Diazepam—Decreased appetite—Capecitabine—esophageal cancer	0.000226	0.00183	CcSEcCtD
Diazepam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000224	0.00182	CcSEcCtD
Diazepam—Vomiting—Cisplatin—esophageal cancer	0.000224	0.00182	CcSEcCtD
Diazepam—Fatigue—Capecitabine—esophageal cancer	0.000224	0.00182	CcSEcCtD
Diazepam—Vision blurred—Methotrexate—esophageal cancer	0.000223	0.00181	CcSEcCtD
Diazepam—CYP3A4—digestive system—esophageal cancer	0.000223	0.0105	CbGeAlD
Diazepam—PTGS1—lung—esophageal cancer	0.000223	0.0105	CbGeAlD
Diazepam—Rash—Cisplatin—esophageal cancer	0.000222	0.0018	CcSEcCtD
Diazepam—Constipation—Capecitabine—esophageal cancer	0.000222	0.0018	CcSEcCtD
Diazepam—Pain—Capecitabine—esophageal cancer	0.000222	0.0018	CcSEcCtD
Diazepam—Dermatitis—Cisplatin—esophageal cancer	0.000222	0.0018	CcSEcCtD
Diazepam—Anaemia—Methotrexate—esophageal cancer	0.000219	0.00178	CcSEcCtD
Diazepam—Feeling abnormal—Capecitabine—esophageal cancer	0.000214	0.00174	CcSEcCtD
Diazepam—Vertigo—Methotrexate—esophageal cancer	0.000213	0.00173	CcSEcCtD
Diazepam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000212	0.00172	CcSEcCtD
Diazepam—Leukopenia—Methotrexate—esophageal cancer	0.000212	0.00172	CcSEcCtD
Diazepam—Ketazolam—ABCB1—esophageal cancer	0.000212	0.0775	CrCbGaD
Diazepam—Nausea—Cisplatin—esophageal cancer	0.000209	0.0017	CcSEcCtD
Diazepam—ABCB1—epithelium—esophageal cancer	0.000207	0.00973	CbGeAlD
Diazepam—Cough—Methotrexate—esophageal cancer	0.000207	0.00168	CcSEcCtD
Diazepam—Urticaria—Capecitabine—esophageal cancer	0.000206	0.00167	CcSEcCtD
Diazepam—Abdominal pain—Capecitabine—esophageal cancer	0.000205	0.00167	CcSEcCtD
Diazepam—Myalgia—Methotrexate—esophageal cancer	0.000202	0.00164	CcSEcCtD
Diazepam—Arthralgia—Methotrexate—esophageal cancer	0.000202	0.00164	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0002	0.00162	CcSEcCtD
Diazepam—Discomfort—Methotrexate—esophageal cancer	0.000199	0.00162	CcSEcCtD
Diazepam—Confusional state—Methotrexate—esophageal cancer	0.000195	0.00158	CcSEcCtD
Diazepam—Anaphylactic shock—Methotrexate—esophageal cancer	0.000193	0.00157	CcSEcCtD
Diazepam—Infection—Methotrexate—esophageal cancer	0.000192	0.00156	CcSEcCtD
Diazepam—Hypersensitivity—Capecitabine—esophageal cancer	0.000191	0.00155	CcSEcCtD
Diazepam—Nervous system disorder—Methotrexate—esophageal cancer	0.00019	0.00154	CcSEcCtD
Diazepam—Thrombocytopenia—Methotrexate—esophageal cancer	0.000189	0.00154	CcSEcCtD
Diazepam—Flurbiprofen—PTGS2—esophageal cancer	0.000188	0.0689	CrCbGaD
Diazepam—Skin disorder—Methotrexate—esophageal cancer	0.000188	0.00152	CcSEcCtD
Diazepam—Hyperhidrosis—Methotrexate—esophageal cancer	0.000187	0.00152	CcSEcCtD
Diazepam—Asthenia—Capecitabine—esophageal cancer	0.000186	0.00151	CcSEcCtD
Diazepam—Anorexia—Methotrexate—esophageal cancer	0.000184	0.00149	CcSEcCtD
Diazepam—Pruritus—Capecitabine—esophageal cancer	0.000184	0.00149	CcSEcCtD
Diazepam—ABCB1—trachea—esophageal cancer	0.000183	0.0086	CbGeAlD
Diazepam—Hypotension—Methotrexate—esophageal cancer	0.000181	0.00147	CcSEcCtD
Diazepam—Diarrhoea—Capecitabine—esophageal cancer	0.000178	0.00144	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000176	0.00143	CcSEcCtD
Diazepam—Insomnia—Methotrexate—esophageal cancer	0.000175	0.00142	CcSEcCtD
Diazepam—Paraesthesia—Methotrexate—esophageal cancer	0.000174	0.00141	CcSEcCtD
Diazepam—Dyspnoea—Methotrexate—esophageal cancer	0.000172	0.0014	CcSEcCtD
Diazepam—Somnolence—Methotrexate—esophageal cancer	0.000172	0.00139	CcSEcCtD
Diazepam—Dizziness—Capecitabine—esophageal cancer	0.000172	0.00139	CcSEcCtD
Diazepam—Dyspepsia—Methotrexate—esophageal cancer	0.00017	0.00138	CcSEcCtD
Diazepam—Decreased appetite—Methotrexate—esophageal cancer	0.000168	0.00136	CcSEcCtD
Diazepam—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000167	0.00135	CcSEcCtD
Diazepam—Fatigue—Methotrexate—esophageal cancer	0.000167	0.00135	CcSEcCtD
Diazepam—Pain—Methotrexate—esophageal cancer	0.000165	0.00134	CcSEcCtD
Diazepam—Vomiting—Capecitabine—esophageal cancer	0.000165	0.00134	CcSEcCtD
Diazepam—Rash—Capecitabine—esophageal cancer	0.000164	0.00133	CcSEcCtD
Diazepam—Dermatitis—Capecitabine—esophageal cancer	0.000164	0.00133	CcSEcCtD
Diazepam—Headache—Capecitabine—esophageal cancer	0.000163	0.00132	CcSEcCtD
Diazepam—Feeling abnormal—Methotrexate—esophageal cancer	0.000159	0.00129	CcSEcCtD
Diazepam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000158	0.00128	CcSEcCtD
Diazepam—ABCB1—digestive system—esophageal cancer	0.000158	0.0074	CbGeAlD
Diazepam—Nausea—Capecitabine—esophageal cancer	0.000154	0.00125	CcSEcCtD
Diazepam—Urticaria—Methotrexate—esophageal cancer	0.000154	0.00125	CcSEcCtD
Diazepam—Abdominal pain—Methotrexate—esophageal cancer	0.000153	0.00124	CcSEcCtD
Diazepam—PTGS1—lymph node—esophageal cancer	0.000152	0.00715	CbGeAlD
Diazepam—Clobazam—ABCB1—esophageal cancer	0.00015	0.0547	CrCbGaD
Diazepam—Hypersensitivity—Methotrexate—esophageal cancer	0.000143	0.00116	CcSEcCtD
Diazepam—Asthenia—Methotrexate—esophageal cancer	0.000139	0.00113	CcSEcCtD
Diazepam—Pruritus—Methotrexate—esophageal cancer	0.000137	0.00111	CcSEcCtD
Diazepam—Diarrhoea—Methotrexate—esophageal cancer	0.000132	0.00107	CcSEcCtD
Diazepam—ABCB1—lung—esophageal cancer	0.000132	0.00618	CbGeAlD
Diazepam—Dizziness—Methotrexate—esophageal cancer	0.000128	0.00104	CcSEcCtD
Diazepam—Nitrazepam—ABCB1—esophageal cancer	0.000124	0.0453	CrCbGaD
Diazepam—Vomiting—Methotrexate—esophageal cancer	0.000123	0.000997	CcSEcCtD
Diazepam—Rash—Methotrexate—esophageal cancer	0.000122	0.000989	CcSEcCtD
Diazepam—Dermatitis—Methotrexate—esophageal cancer	0.000122	0.000988	CcSEcCtD
Diazepam—Headache—Methotrexate—esophageal cancer	0.000121	0.000982	CcSEcCtD
Diazepam—Clomipramine—ABCB1—esophageal cancer	0.000118	0.0433	CrCbGaD
Diazepam—Chlorprothixene—ABCB1—esophageal cancer	0.000118	0.0431	CrCbGaD
Diazepam—Nausea—Methotrexate—esophageal cancer	0.000115	0.000931	CcSEcCtD
Diazepam—Flurazepam—ABCB1—esophageal cancer	0.00011	0.0402	CrCbGaD
Diazepam—Midazolam—ABCB1—esophageal cancer	0.000102	0.0373	CrCbGaD
Diazepam—ABCB1—lymph node—esophageal cancer	9.01e-05	0.00423	CbGeAlD
Diazepam—Clozapine—ABCB1—esophageal cancer	8.63e-05	0.0316	CrCbGaD
Diazepam—CYP2C19—Metabolism—TPI1—esophageal cancer	1.48e-05	8.84e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.48e-05	8.84e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.47e-05	8.78e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.47e-05	8.76e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.45e-05	8.67e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—TPI1—esophageal cancer	1.45e-05	8.63e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSTO1—esophageal cancer	1.45e-05	8.63e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GNG7—esophageal cancer	1.44e-05	8.61e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—GNG7—esophageal cancer	1.44e-05	8.56e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—ENO1—esophageal cancer	1.42e-05	8.5e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.42e-05	8.5e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.42e-05	8.47e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.42e-05	8.45e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.41e-05	8.38e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PSME2—esophageal cancer	1.4e-05	8.37e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PSME1—esophageal cancer	1.4e-05	8.37e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.4e-05	8.32e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—ENO1—esophageal cancer	1.4e-05	8.32e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—ENO1—esophageal cancer	1.39e-05	8.31e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.39e-05	8.31e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—ALDOB—esophageal cancer	1.39e-05	8.27e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—CREBBP—esophageal cancer	1.38e-05	8.26e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.38e-05	8.25e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CA1—esophageal cancer	1.38e-05	8.25e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PSME2—esophageal cancer	1.38e-05	8.2e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PSME1—esophageal cancer	1.38e-05	8.2e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PSME2—esophageal cancer	1.37e-05	8.18e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PSME1—esophageal cancer	1.37e-05	8.18e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.37e-05	8.16e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—HMOX1—esophageal cancer	1.36e-05	8.12e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—CREBBP—esophageal cancer	1.36e-05	8.09e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.36e-05	8.08e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.35e-05	8.07e-05	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.35e-05	8.07e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—TPI1—esophageal cancer	1.35e-05	8.06e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.35e-05	8.06e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.35e-05	8.05e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—ALDH2—esophageal cancer	1.35e-05	8.03e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.34e-05	7.97e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.34e-05	7.97e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GAPDH—esophageal cancer	1.33e-05	7.96e-05	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.33e-05	7.95e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CRABP1—esophageal cancer	1.32e-05	7.89e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—ABCB1—esophageal cancer	1.31e-05	7.8e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.3e-05	7.73e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GNG7—esophageal cancer	1.29e-05	7.69e-05	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.29e-05	7.69e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.29e-05	7.68e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—GSTT1—esophageal cancer	1.28e-05	7.63e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—TYMP—esophageal cancer	1.28e-05	7.61e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.27e-05	7.59e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.27e-05	7.56e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CYP2A6—esophageal cancer	1.27e-05	7.55e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CA2—esophageal cancer	1.26e-05	7.54e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.26e-05	7.52e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GNG7—esophageal cancer	1.26e-05	7.5e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.25e-05	7.44e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.24e-05	7.41e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—NOS3—esophageal cancer	1.24e-05	7.39e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.24e-05	7.37e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—NOS3—esophageal cancer	1.21e-05	7.24e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.21e-05	7.23e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.21e-05	7.22e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.21e-05	7.2e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.21e-05	7.19e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—ENO1—esophageal cancer	1.21e-05	7.19e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—ENO1—esophageal cancer	1.2e-05	7.15e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTGS1—esophageal cancer	1.2e-05	7.15e-05	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.2e-05	7.15e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PSME2—esophageal cancer	1.19e-05	7.09e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PSME1—esophageal cancer	1.19e-05	7.09e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.19e-05	7.08e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.18e-05	7.06e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PSME2—esophageal cancer	1.18e-05	7.05e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PSME1—esophageal cancer	1.18e-05	7.05e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—ALDH2—esophageal cancer	1.18e-05	7.03e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ADH7—esophageal cancer	1.18e-05	7.01e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.18e-05	7.01e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GNG7—esophageal cancer	1.18e-05	7.01e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—TPI1—esophageal cancer	1.15e-05	6.89e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.15e-05	6.89e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.15e-05	6.85e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.14e-05	6.79e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.14e-05	6.77e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.13e-05	6.75e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSTT1—esophageal cancer	1.12e-05	6.69e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.12e-05	6.65e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.11e-05	6.64e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PTGS2—esophageal cancer	1.11e-05	6.62e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.11e-05	6.61e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.11e-05	6.6e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.1e-05	6.57e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.08e-05	6.42e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—ENO1—esophageal cancer	1.08e-05	6.42e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.07e-05	6.35e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PSME1—esophageal cancer	1.06e-05	6.33e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PSME2—esophageal cancer	1.06e-05	6.33e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.06e-05	6.3e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—ENO1—esophageal cancer	1.05e-05	6.27e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTGS1—esophageal cancer	1.05e-05	6.27e-05	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.05e-05	6.26e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.05e-05	6.25e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.04e-05	6.2e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.04e-05	6.19e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.04e-05	6.18e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PSME1—esophageal cancer	1.04e-05	6.18e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PSME2—esophageal cancer	1.04e-05	6.18e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.03e-05	6.16e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.03e-05	6.15e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.03e-05	6.15e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.03e-05	6.12e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CYP1B1—esophageal cancer	1.02e-05	6.08e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.02e-05	6.07e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.02e-05	6.06e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GNG7—esophageal cancer	1e-05	5.99e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—ABCB1—esophageal cancer	9.98e-06	5.95e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.89e-06	5.9e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—TYMP—esophageal cancer	9.85e-06	5.88e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—ENO1—esophageal cancer	9.82e-06	5.85e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTGS1—esophageal cancer	9.82e-06	5.85e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—ABCB1—esophageal cancer	9.77e-06	5.83e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—ABCB1—esophageal cancer	9.75e-06	5.82e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PSME2—esophageal cancer	9.67e-06	5.77e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PSME1—esophageal cancer	9.67e-06	5.77e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.64e-06	5.75e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CYP19A1—esophageal cancer	9.59e-06	5.72e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.58e-06	5.72e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—EP300—esophageal cancer	9.43e-06	5.62e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.41e-06	5.61e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.34e-06	5.57e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.26e-06	5.53e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—EP300—esophageal cancer	9.24e-06	5.51e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CYP1B1—esophageal cancer	9.15e-06	5.46e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CREBBP—esophageal cancer	9.02e-06	5.38e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSTT1—esophageal cancer	8.95e-06	5.34e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CYP1B1—esophageal cancer	8.93e-06	5.33e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—TPI1—esophageal cancer	8.91e-06	5.31e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSTO1—esophageal cancer	8.91e-06	5.31e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP2A6—esophageal cancer	8.85e-06	5.28e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.81e-06	5.26e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—HMOX1—esophageal cancer	8.8e-06	5.25e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—HMOX1—esophageal cancer	8.75e-06	5.22e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CREBBP—esophageal cancer	8.74e-06	5.21e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.63e-06	5.15e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CYP19A1—esophageal cancer	8.61e-06	5.13e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.58e-06	5.12e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.54e-06	5.1e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.45e-06	5.04e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.45e-06	5.04e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.4e-06	5.01e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—ABCB1—esophageal cancer	8.4e-06	5.01e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ENO1—esophageal cancer	8.39e-06	5e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.39e-06	5e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.35e-06	4.98e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PSME2—esophageal cancer	8.27e-06	4.93e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PSME1—esophageal cancer	8.27e-06	4.93e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.22e-06	4.9e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.15e-06	4.86e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—NOS3—esophageal cancer	8.07e-06	4.81e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—HMOX1—esophageal cancer	7.85e-06	4.68e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	7.85e-06	4.68e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—NOS3—esophageal cancer	7.82e-06	4.67e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GNG7—esophageal cancer	7.75e-06	4.62e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.7e-06	4.6e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—HMOX1—esophageal cancer	7.67e-06	4.57e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—ABCB1—esophageal cancer	7.54e-06	4.5e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PTGS2—esophageal cancer	7.38e-06	4.4e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.26e-06	4.33e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.22e-06	4.31e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.16e-06	4.27e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PTGS2—esophageal cancer	7.16e-06	4.27e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.13e-06	4.25e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.03e-06	4.19e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PIK3CA—esophageal cancer	6.97e-06	4.16e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.91e-06	4.12e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—ABCB1—esophageal cancer	6.87e-06	4.1e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PIK3CA—esophageal cancer	6.83e-06	4.07e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.83e-06	4.07e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—TP53—esophageal cancer	6.75e-06	4.02e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.71e-06	4e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CREBBP—esophageal cancer	6.67e-06	3.98e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CREBBP—esophageal cancer	6.53e-06	3.89e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CREBBP—esophageal cancer	6.52e-06	3.89e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ENO1—esophageal cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PSME2—esophageal cancer	6.38e-06	3.8e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PSME1—esophageal cancer	6.38e-06	3.8e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.35e-06	3.79e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—EP300—esophageal cancer	6.14e-06	3.66e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.12e-06	3.65e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6e-06	3.58e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—NOS3—esophageal cancer	5.97e-06	3.56e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—EP300—esophageal cancer	5.95e-06	3.55e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.87e-06	3.5e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—NOS3—esophageal cancer	5.85e-06	3.49e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—NOS3—esophageal cancer	5.83e-06	3.48e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.7e-06	3.4e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.64e-06	3.37e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CREBBP—esophageal cancer	5.61e-06	3.35e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.5e-06	3.28e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PTGS2—esophageal cancer	5.46e-06	3.26e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PTGS2—esophageal cancer	5.35e-06	3.19e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.34e-06	3.18e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.2e-06	3.1e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.18e-06	3.09e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—NOS3—esophageal cancer	5.05e-06	3.01e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.04e-06	3e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—NOS3—esophageal cancer	5.02e-06	3e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CREBBP—esophageal cancer	4.92e-06	2.93e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.72e-06	2.82e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.62e-06	2.76e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTGS2—esophageal cancer	4.6e-06	2.74e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.59e-06	2.74e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PIK3CA—esophageal cancer	4.54e-06	2.71e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—EP300—esophageal cancer	4.54e-06	2.71e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.53e-06	2.7e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—NOS3—esophageal cancer	4.51e-06	2.69e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—EP300—esophageal cancer	4.45e-06	2.65e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.44e-06	2.65e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—EP300—esophageal cancer	4.44e-06	2.65e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—NOS3—esophageal cancer	4.4e-06	2.63e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PIK3CA—esophageal cancer	4.4e-06	2.63e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.13e-06	2.46e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—NOS3—esophageal cancer	4.11e-06	2.45e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTGS2—esophageal cancer	4.03e-06	2.4e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.93e-06	2.34e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—EP300—esophageal cancer	3.84e-06	2.29e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—EP300—esophageal cancer	3.82e-06	2.28e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.76e-06	2.24e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—NOS3—esophageal cancer	3.51e-06	2.1e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—EP300—esophageal cancer	3.43e-06	2.05e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.36e-06	2e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—EP300—esophageal cancer	3.35e-06	2e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PIK3CA—esophageal cancer	3.29e-06	1.96e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.28e-06	1.96e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.21e-06	1.92e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—EP300—esophageal cancer	3.13e-06	1.87e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.03e-06	1.81e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.84e-06	1.7e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PIK3CA—esophageal cancer	2.83e-06	1.69e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—NOS3—esophageal cancer	2.71e-06	1.62e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—EP300—esophageal cancer	2.67e-06	1.59e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.54e-06	1.51e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.48e-06	1.48e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.48e-06	1.48e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.31e-06	1.38e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—EP300—esophageal cancer	2.06e-06	1.23e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.98e-06	1.18e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.53e-06	9.1e-06	CbGpPWpGaD
